⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC

TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC

Unclaimed

AEO Score: 7/10

Monitoring for AI engine activity

In the Engagemii AEO index

tagrissohcp.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC just got measured.

7/10 means TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.

About TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC

Discover TAGRISSO® (osimertinib) newly approved indications for treating resectable, locally advanced, and metastatic EGFRm NSCLC, offering patients targeted therapy options across all stages.

Key Topics

Treat the driver of disease with TAGRISSO

Details

Industry: Healthcare

tagrissohcp.com

AI Visibility Breakdown

5

Structured Data

8

Content Structure

6

Entity Clarity

5

E-E-A-T Signals

8

Technical AEO

7

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC: Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC.

Source & Attribution

Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/tagrissohcp

Cite this score: Engagemii (2026). "AEO Score for TAGRISSO for Resectable, Unresectable & Metastatic EGFRm NSCLC." Retrieved from https://engagemii.com/aeo/brands/tagrissohcp

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform